1. Introduction
===============

Hydrazide-hydrazones are an important class of compounds that has gained much importance in recent years due to their diverse biological activities \[[@B1-molecules-15-03602],[@B2-molecules-15-03602],[@B3-molecules-15-03602],[@B4-molecules-15-03602],[@B5-molecules-15-03602],[@B6-molecules-15-03602],[@B7-molecules-15-03602],[@B8-molecules-15-03602],[@B9-molecules-15-03602],[@B10-molecules-15-03602]\]. The therapeutic prominence of hydrazide-hydrazone derivatives is well established \[[@B11-molecules-15-03602],[@B12-molecules-15-03602]\]. Hydrazide-hydrazones were also reported to elicit anticancer \[[@B13-molecules-15-03602],[@B14-molecules-15-03602],[@B15-molecules-15-03602],[@B16-molecules-15-03602],[@B17-molecules-15-03602],[@B18-molecules-15-03602],[@B19-molecules-15-03602],[@B20-molecules-15-03602]\] and anti-HIV properties \[[@B21-molecules-15-03602]\] and hence they have gained an important place in medicinal chemistry. The discovery of the antineoplastic activity of the naturally occurring Schiff's bases has stimulated considerable research efforts in the field of condensed systems \[[@B22-molecules-15-03602]\]. With the aim of constructing such condensed systems with the hydrazide-hydrazone nucleus, we turned our attention to using such compounds as synthons for heterocyclic derivatives and their anitumor evaluation \[[@B23-molecules-15-03602],[@B24-molecules-15-03602]\].

2. Results and Discussion
=========================

In this work we report the reaction of cyanoacetylhydrazine (**1**) with ω-bromo-(4-methyl-acetophenone) (**2**) in 1,4-dioxane which gave the condensed product **3**. The structure of compound **3** was confirmed based on analytical and spectral data. Thus, the ^1^H-NMR showed a singlet at δ 2.51 for the CH~3~, two singlets at δ 4.31, 4.72 for the two CH~2~ groups, a multiplet at δ 6.50--7.76 for the C~6~H~4~ group and a singlet at δ 11.46 (D~2~O exchangeable) for the NH group. The reactivity of compound **3** towards different chemical reagents was studied. The reaction of **3** with either potassium cyanide or potassium thiocyanate gave the corresponding cyanide or the thiocyanate derivatives **4a** and **4b**, respectively ([Scheme 1](#molecules-15-03602-f001){ref-type="fig"}).

![Synthesis of the hydrazide-hydrazone **3** and **4a**, **b**.](molecules-15-03602-g001){#molecules-15-03602-f001}

The reaction of compound **3** with either hydrazine hydrate (**5a**) or phenylhydrazine (**5b**) gave the hydrazine derivative **6a** or **6b**, respectively. Analytical and spectral data of the reaction products are in agreement with the proposed structures (see Experimental section). The reaction of either **6a** or **6b** with benzaldehyde (**7**) gave the benzal derivative **8a** or **8b**, respectively ([Scheme 2](#molecules-15-03602-f002){ref-type="fig"}).

![Synthesis of the hydrazine derivatives **6a**, **b** and **8a**, **b**.](molecules-15-03602-g002){#molecules-15-03602-f002}

On the other hand, the reaction of either **6a** or **6b** with either benzenediazonium chloride (**9a**), 3-cyano-4,5,6,7-tetrahydrobenzo\[b\]thiophene-2-diazonium chloride (**9b**) or ethyl 3-cyano-4,5,6,7-tetrahydrobenzo\[b\]thiophene-3-carboxylate-2-diazonium chloride (**9c**) gave the 3-(α-hydrazo-acetonitrilo)-1,2,4-triazine derivatives **10a--f**, respectively ([Scheme 3](#molecules-15-03602-f003){ref-type="fig"}). The analytical and spectral data of the latter reaction products are all consistent with the proposed structures.

![Synthesis of the 1,2,4-triazines **10a--f**.](molecules-15-03602-g003){#molecules-15-03602-f003}

Next, we moved towards studying the reactivity of **6a** and **6b** with active methylene reagents. Thus, their reactions with either malononitrile (**11a**) or ethyl cyanoacetate (**11b**) gave the pyridine derivatives **12a--d**, respectively ([Scheme 4](#molecules-15-03602-f004){ref-type="fig"}). The structures of the latter products were established on the basis of their analytical and spectral data. Thus, the ^1^H-NMR spectrum of **12c**showed a singlet at δ 2.51 for the CH~3~ group, a singlet at δ 3.38 for the CH~2~ group, two singlets at δ 4.38, 4.79 for the two NH~2~ groups and a multiplet at δ 6.48--8.19 for the pyridine H-3, C~6~H~5~and C~6~H~4~, two singlets at δ 10.82, 11.20 for the two NH groups, respectively.

![Synthesis of 2-oxopyridines **12a--d**.](molecules-15-03602-g004){#molecules-15-03602-f004}

On the other hand, the reaction of either **6a** or **6b** with either acetylacetone (**13a**) or ethyl acetoacetate (**13b**) gave the pyridine derivatives **14a--d**, respectively ([Scheme 5](#molecules-15-03602-f005){ref-type="fig"}). The structures of the latter products were confirmed by their analytical and spectral data (see Experimental section).

![Synthesis of 2-oxopyridines **14a--d**.](molecules-15-03602-g005){#molecules-15-03602-f005}

Compound **3** underwent ready cyclization when heated in sodium ethoxide solution to give the 1,3,4-oxadiazine derivative **15**, whose structure was established from its analytical and spectral data (see Experimental section). The oxadiazine derivatives **15**seemed to be an intermediate for many reactions between **3** and many chemical reagents. Thus, the reaction of **3** with benzaldehyde (**7**) gave the 2-(α-benzalacetonitrilo)-1,3,4-oxadiazine derivative **16**. The analytical and spectral data of **16** were in agreement with the proposed structure. Thus, the ^1^H-NMR spectrum showed a singlet at δ 2.51 for the CH~3~ group, a singlet at δ 4.22 for the CH~2~ group, a singlet at δ 5.16 for the (=CH) group and a multiplet at δ 7.35--8.02 for the C~6~H~5~and C~6~H~4~groups. The same product **16** was obtained through the reaction of compound **15** with benzaldehyde (**7**) (confirmed by m.p., mixed m.p. and fingerprint IR spectrum). On the other hand, the reaction of **15** with benzenediazonium chloride (**9**) gave the 2-(α-phenylhydrazo)-1,3,4-oxadiazine derivative **17**([Scheme 6](#molecules-15-03602-f006){ref-type="fig"}).

![Synthesis of 1,3,4-oxadiazines **15**, **16** and **17**.](molecules-15-03602-g006){#molecules-15-03602-f006}

Effect on the Growth of Human Tumor Cell Lines
----------------------------------------------

The effect of compounds **4**--**17** was evaluated on the *in vitro* growth of three human tumor cell lines representing different tumor types, namely, breast adenocarcinoma (MCF-7), non-small cell lung cancer (NCI-H460) and CNS cancer (SF-268), after a continuous exposure of 48 h. The results are summarized in [Table 1](#molecules-15-03602-t001){ref-type="table"}. All the compounds were able to inhibit the growth of the tested human tumor cell lines in a dose-dependent manner (data not shown). The results showed that compound **14b**, with its 2-hydroxypyridine group, showed the highest inhibitory effect against all the three tumor cell lines. In addition compounds **10a**, **10f**, **12a**, **12b** and **14c** showed high inhibitory effects. On the other hand, compounds **4b**, **6a**, **8b**, **10b**, **10d**, **12c**, **12d**, **14a**, **14c**, **16** and **17** showed the lowest inhibitory effect towards adenocarcinoma (MCF-7). The rest of compounds showed the moderate growth inhibitory effects. Comparing compound **4a** with **4b**, it is obvious that the presence of the α-SCN present in **4b** showed lower inhibitory effect than **4a** with it's α-CN group. Comparing 1,2,4-triazine derivatives **10a** (with the 4-phenylamino group) and **10b** (with the 4-thiophenoamino group), the first has a greater inhibitory effect than the second towards the three cell lines.

molecules-15-03602-t001_Table 1

###### 

Effect of the newly synthesized products on the growth of three human tumor cell lines.

  Compound   GI~50~(μΜ)                  
  ---------- ------------- ------------- ------------
  **4a**     10.0 ± 0.6    12.9 ± 1.6    15 ± 1.1
  **4b**     70.6 ± 15.3   38.1 ± 10.8   48.0 ± 9.1
  **6a**     50.8 ± 18.5   20.2 ± 12.6   50.0 ± 8.7
  **6b**     25.8 ± 12.5   22.4 ± 8.6    20.3 ± 8.6
  **8a**     24.6\*        77.9 ± 5.0    35.0\*
  **8b**     80.9 ± 10.2   70.9 ± 6.1    50.2 ± 2.2
  **10a**    8.0 ± 0.6     11.7 ± 8.8    14.8 ± 1.6
  **10b**    70.6 ± 8.6    55.6 ± 5.8    42.6 ± 8.6
  **10c**    24.2 ± 0.6    8.4 ± 1.8     10.4 ± 8.4
  **10d**    88.4 ± 4.3    66.8 ± 12.0   40.9 ± 2.6
  **10e**    12.4 ± 2.6    6.8 ± 1.2     8.3 ± 9.2
  **10f**    10.0 ± 0.4    14.9 ± 1.6    14 ± 1.1
  **12a**    12.4 ± 1.6    10.8 ± 4.0    16 ± 6.0
  **12b**    8.6 ± 2.4     10.4 ± 6.2    12.0 ± 4.2
  **12c**    86.8 ± 6.0    48.5 ± 4.0    38.4 ± 2.6
  **12d**    90.8 ± 2.4    78.2 ± 2.2    86.2 ± 1.8
  **14a**    66.4 ± 6.0    42.4 ± 6.0    62.3 ± 6.0
  **14b**    4.2 ± 2.8     10.2 ± 6.8    10.8 ± 5.0
  **14c**    80.3 ± 4.0    64.8 ± 6.4    50.8 ± 6.4
  **16**     40.5 ± 2.6    32.6 ± 4.0    26.8 ± 8.4
  **17**     60.4 ± 6.0    77.8 ± 3.1    47.0 ± 6.4

Results are given in concentrations that were able to cause 50% of cell growth inhibition (GI~50~) after a continuous exposure of 48 h and show means ± SEM of three-independent experiments performed in duplicate. ^\*^Results from two-independent experiments performed in duplicate. Doxorubicin was used as positive control, GI~50~: MCF-7 = 42.8 ± 8.2 nM, NCI-H460 = 94.0 ± 8.7 nM, and SF-268 = 94.0 ± 7.0 nM.

3. Experimental
===============

3.1. General
------------

Melting points were determined on an Electrothermal melting point apparatus (Electrothermal 9100) and are uncorrected. IR spectra were recorded for KBr discs on a Pye Unicam SP-1000 spectrophotometer. ^1^H-NMR & ^13^C-NMR spectra were measured on a Varian EM-390-200 MHz in CD~3~SOCD~3~ as solvent using TMS as internal standard, and chemical shifts are expressed as δ. Analytical data were obtained from the Microanalytical Data Unit at Cairo University, Giza, Egypt. Antitumor evaluation for the newly synthesized products were performed by a research group at the National Research Center & the National Cancer Institute at Cairo University.

*4-Methyl-ω-bromoacetophenone cyanoacetylhydrazone*(**3**)*.* To a solution of cyanoacetylhydrazine (**1**, 2.44 g, 0.02 mol) in 1,4-dioxane (20 mL), ω-bromo-(4-methylacetophenone) (5.24 g, 0.02 mol) was added. The reaction mixture was stirred at room temperature for 1 hr then poured onto a beaker containing an ice/water mixture. The solid product formed was collected by filtration and dried obtaining pale yellow crystals (from ethanol).Yield: 5.02 g (71%), m.p. 148 °C; IR (KBr) υ/cm^−1^: 3400--3378 (NH), 3105 (CH aromatic), 2956 (CH~3~), 2259 (CN), 1681 (C=O), 1610 (C=C);^1^H-NMR δ: 2.51 (s, 3H, CH~3~), 4.31, 4.72 (2s, 4H, CH~2~), 6.50--7.76 (m, 4H, C~6~H~4~), 11.46 (s, 1H, NH). MS: (m/z) 293 (M^.+^) (6%), 200 (28%), 117 (100%), 68 (69.9%); ^13^C-NMR: 22.6 (CH~3~), 27.0, 58.7 (2CH~2~), 118.5 (CN), 126.8, 128.4, 129.5, 138.8 (C~6~H~5~), 156.3 (C=N), 173.8 (C=O); *Anal.* Calcd. for C~12~H~12~N~3~OBr (294.24): C, 48.00; H, 4.11; N, 14.29%. Found: C, 49.27; H, 4.45; N, 14.35%.

3.2. General Procedure for the Synthesis of ***4a*** or ***4b***
----------------------------------------------------------------

To a solution of **3** (0.54 g, 1.83 × 10^−3^ mol) in ethanol (25 mL) in a water bath at 60 °C, either potassium cyanide (0.11 g, 1.83 × 10^−3^ mol) or potassium thiocyanate (0.17 g, 1.83 × 10^−3^ mol) was added with continuous stirring. The reaction mixture was left in the water bath for 30 min at 60 °C then poured onto a beaker containing ice/water mixture and few drops of hydrochloric acid. The formed solid product was collected by filtration and dried.

*4-Methyl-ω-cyanoacetophenonecyanoacetylhydrazone*(**4a**). Pale brown crystals (from ethanol).Yield: 0.20 g (62%), m.p. 160 °C; IR (KBr) υ/cm^−1^: 3450--3205 (NH), 3031 (CH aromatic), 2260, 2209 (2CN), 1680 (C=O); ^1^H NMR δ: 2.39 (s, 3H, CH~3~), 4.46, 5.06 (2s, 4H, 2CH~2~), 7.18--7.84 (m, 4H, C~6~H~4~), 10.82 (s, 1H, NH); ^13^C NMR: 23.8 (CH~3~), 27.3, 29.5 (2CH~2~), 116.9, 117.0 (2CN), 127.3, 128.0, 129.8, 138.9 (C~6~H~4~), 155.8 (C=N), 173.8 (C=O); *Anal.* Calcd. for C~13~H~12~N~4~O (240.26): C, 64.99; H, 5.03; N, 23.32%. Found: C, 64.79; H, 5.11; N, 22.99%.

*4-Methyl-ω-thiocyanoacetophenoecyanoacetylhydrazone*(**4b**). Buff crystals (from ethanol). Yield: 0.33 g (67%), m.p. 130 °C; IR (KBr) υ/cm^−1^: 3445--3225 (NH), 3099 (CH aromatic), 3034 (CH~3~), 2969, 2925 (2CH~2~), 2264, 2225 (2CN), 1666 (C=O), 1606 (C=C); ^1^H-NMR δ: 2.49 (s, 3H, CH~3~), 4.50, 5.08 (2s, 4H, 2CH~2~), 7.06--7.93 (m, 4H, C~6~H~4~), 11.52 (s, 1H, NH); ^13^C-NMR: 23.8 (CH~3~), 27.3, 29.4 (2CH~2~), 116.7, 117.8 (2CN), 127.0, 128.3, 129.6, 138.6 (C~6~H~4~), 155.5 C=N), 173.9 (C=O); *Anal.* Calcd for C~13~H~12~N~4~OS (272.32): C, 57.33; H, 4.44; N, 20.57; S, 11.77%. Found: C, 57.38; H, 4.64; N, 20.68; S, 11.57%.

3.3. General Procedure for the Synthesis of ***6a*** and ***6b***
-----------------------------------------------------------------

To a solution of compound **3** (1.50 g, 5.09 × 10^−3^ mol) in ethanol (35 mL) either hydrazine hydrate (0.25 g, 5.09 × 10^−3^ mol) or phenylhydrazine (0.55 g, 5.09 × 10^−3^ mol) was added. The reaction mixture was heated under reflux for 3 hrs then poured onto a beaker containing an ice/water mixture and a few drops of hydrochloric acid. The formed solid product was collected by filtration and dried.

*4-Methyl-ω-hydrazinoacetophenonecyanoacetylhydrazone*(**6a**). Greenish brown crystals (from ethanol). Yield: 0.65 g (52%), m.p. 120 °C; IR (KBr) υ/cm^−1^: 3400--3204 (NH~2~, 2NH), 3027 (CH aromatic), 2918 (CH~3~), 2203 (CN), 1688 (C=O), 1607 (C=C); ^1^H-NMR δ: 2.51 (s, 3H, CH~3~), 3.39, 4.23 (2s, 4H, 2CH~2~), 4.82 (s, 2H, NH~2~), 6.87--8.40 (m, 4H, C~6~H~4~), 9.26, 11.41 (2s, 2H, 2NH); ^13^C-NMR: 23.6 (CH~3~), 27.0, 29.6 (2CH~2~), 127.8, 128.3, 129.5, 138.6 (C~6~H~4~), 155.6, 164.2 (2C=N), 173.8 (C=O); *Anal.* Calcd. for C~12~H~15~N~5~O (245.28): C, 58.76; H, 6.16; N, 28.55%. Found: C, 58.55; H, 5.96; N, 28.32%.

*4-Methyl-ω-phenylhydrazinoacetophenonecyanoacetylhydrazone*(**6b**)*.* Brown crystals (from ethanol). Yield: 0.95 g (63%), m.p. 72 °C; IR (KBr) υ/cm^−1^: 3500--3174 (3NH), 3026 (CH aromatic), 2969 (CH~3~), 2205 (CN), 1687 (C=O), 1600 (C=C); ^1^H-NMR δ: 2.51 (s, 3H, CH~3~), 3.39, 4.35 (2s, 4H, 2CH~2~), 6.79--8.40 (m, 9H, C~6~H~5~, C~6~H~4~), 10.82, 11.19, 12.63 (3s, 3H, 3NH); ^13^C-NMR: 23.6 (CH~3~), 27.0, 29.9 (2CH~2~), 120.3, 122.5, 127.3, 128.4, 129.3, 138.5, 140.1 (C~6~H~4~, C~6~H~5~), 155.6, 164.2 (2C=N), 173.8 (C=O); *Anal.* Calcd. for C~18~H~19~N~5~O (321.38): C, 67.27; H, 5.96; N, 21.79%. Found: C, 67.37; H, 5.84; N, 22.61%.

*α-Benzal-4-methyl-ω-hydrazinoacetophenonecyanoacetylhydrazone*(**8a**)*:*To a solution of compound **6a**(0.29 g, 1.18 × 10^−3^ mol) in ethanol (25 mL) containing piperidine (0.5 mL), benzaldehyde (0.11 g, 1.48 × 10^−3^ mol) was added. The reaction mixture was heated under reflux for 3hrs then poured onto a beaker containing an ice/water mixture and few drops of hydrochloric acid. The formed solid product was collected by filtration and dried obtaining deep yellowish brown crystals (from ethanol).Yield: 0.26 g (66%), m.p. 90 °C; IR (KBr) υ/cm^−1^: 3500--3194 (NH~2~, 2NH), 3027 (CH aromatic), 2919 (CH~3~), 2218 (CN), 1680 (C=O), 1608 (C=C); ^1^H-NMR δ: 2.51 (s, 3H, CH~3~), 3.36 (s, 2H, CH~2~), 4.77 (s, 2H, NH~2~), 5.99 (s, 1H, =CH), 7.27--8.40 (m, 9H, C~6~H~5~, C~6~H~4~), 8.81, 9.15 (2s, 2H, 2NH); ^13^C-NMR: 23.2 (CH~3~), 27.4, 29.2 (2CH~2~), 122.3, 122.8, 122.5, 126.0 128.3, 129.9, 138.3 (C~6~H~5~, C~6~H~4~) 155.0, 164.3 (2C=N), 174.3 (C=O); *Anal.* Calcd. for C~19~H~19~N~5~O (333.39): C, 68.45; H, 5.74; N, 21.01%. Found: C, 68.55; H, 5.54; N, 21.31%.

*α-Benzal-4-methyl-ω-phenylhydrazinoacetophenonecyanoacetyl-hydrazone*(**8b**)**.**To a solution of compound **6b**(0.36 g, 1.12 × 10^−3^ mol) in ethanol (25 mL) containing piperidine (0.5 mL), benzaldehyde (0.11 g, 1.12 × 10^−3^ mol) was added. The reaction mixture was heated under reflux for 3hrs then poured onto a beaker containing an ice/water mixture and a few drops of hydrochloric acid. The formed solid product was collected by filtration and dried obtaining yellowish brown crystals (from ethanol). Yield: 0.33 g (73%), m.p. 102 °C; IR (KBr) υ/cm^−1^: 3300-3179 (3NH), 3026 (CH aromatic), 2920 (CH~3~), 2210 (CN), 1688 (C=O), 1600 (C=C); ^1^H NMR δ: 2.88 (s, 3H, CH~3~), 3.37 (s, 2H, CH~2~), 6.90--8.40 (m, 15H, =CH, 2C~6~H~5~, C~6~H~4~), 9.20, 10.83, 12.62 (3s, 3H, 3NH); ^13^C-NMR: 23.2 (CH~3~), 27.4, 29.2 (2CH~2~), 120.9, 121.1, 122.3, 122.8, 123.4, 123.9, 122.5, 126.0 128.3, 129.5, 138.6 (2C~6~H~5~, C~6~H~4~) 155.3, 164.0 (2C=N), 174.6 (C=O); *Anal.* Calcd. for C~25~H~23~N~5~O (409.48): C, 73.33; H, 5.66; N, 17.10%. Found: C, 73.52; H, 5.97; N, 17.33%.

*1-Amino-6-(4-methylphenyl)-3-(α-phenylhydrazoacetonitrilo)-1,2,4-triazine*(**10a**)**.**To a cold solution (0--5 °C) of compound **6a**(0.40 g, 1.63 × 10^−3^ mol) in ethanol (50 mL) containing sodium hydroxide (10 mL, 10%) and a solution of benzenediazonium chloride (1.63 × 10^−3^ mol) \[which was prepared by dissolving sodium nitrite (0.16 g, 2.44 × 10^−3^ mol) in water, 2 mL was added to a cold solution of aniline (0.15 g, 1.63 × 10^−3^ mol) containing the appropriate amount of hydrochloric acid and with continuous stirring\] was added with continuous stirring. The formed solid product was collected by filtration and dried to give reddish brown crystals (from ethanol and few drops of dimethylformamide). Yield: 0.58 g (63%), m.p. 170 °C; IR (KBr) υ/cm^−1^: 3400--3307 (NH~2~, NH), 3027 (CH aromatic), 2919, 2862 (CH~3~, CH~2~), 2211 (CN), 1600 (C=C); ^1^H-NMR δ: 2.51 (s, 3H, CH~3~), 3.37 (s, 2H, CH~2~), 4.22 (s, 2H, NH~2~), 6.50--8.20 (m, 9H, C~6~H~5~, C~6~H~4~), 11.64 (s, 1H, NH); ^13^C-NMR: 23.8 (CH~3~), 51.9 (triazine CH~2~), 115.8 (CN), 118.3, 118.9, 119.2, 121.6, 124.8, 133.0, 139.6 (C~6~H~5~, C~6~H~4~), 156.9, 163.8 164.1 (3 C=N); *Anal.* Calcd. for C~18~H~17~N~7~ (331.38): C, 65.24; H, 5.17; N, 29.58%. Found: C, 65.42; H, 5.27; N, 29.36%.

3.4. General Procedure for the Synthesis of ***10b*** and ***10c***
-------------------------------------------------------------------

To a cold solution (0--5 °C) of compound **6a**(0.49 g, 1.99 × 10^−3^ mol) in ethanol (50 mL) containing sodium hydroxide solution (10 mL, 10%) was added with continuous stirring a solution of either 3-cyano-4,5,6,7-terahydrobenzo\[b\]thiophene-2-diazonium chloride (**9b**) (1.99 × 10^−3^ mol) or ethyl 4,5,6,7-tetrahydrobenzo\[b\]thiophene-3-carboxylate-2-diazonium chloride (**9c**) (1.99 × 10^−3^ mol) \[which was prepared by dissolving sodium nitrite (0.20 g, 2.99 × 10^−3^ mol) in water, 2 mL was added to a cold solution of either the 2-amino-3-cyano-4,5,6,7-tetrahydrobenzo\[b\]thiophene (0.35 g, 1.99 × 10^−3^ mol) or ethyl 2-amino-4,5,6,7-tetrahydrobenzo\[b\]thiophene-3-carboxylate (0.45 g, 1.99 × 10^−3^ mol) dissolved in acetic acid (50 mL) containing the appropriate amount of hydrochloric acid and with continuous stirring\]. The solid product formed was collected by filtration and dried.

*1-Amino-6-(4-methylphenyl)-3-(α-(3-cyano-2-hydrazo-4,5,6,7-tetra-hydrobenzo\[b\]thiophene)aceto-nitrilo)-1,2,4-triazine*(**10b**). Deep brown crystals (from ethanol). Yield: 0.67 g (75%), m.p. 210--214 °C; IR (KBr) υ/cm^−1^: 3600--3425 (NH~2~, NH), 3030 (CH aromatic), 2930 (CH~3~), 2250, 2217 (2CN), 1606 (C=C); ^1^H-NMR δ: 1.63--2.34 (m, 8H, cyclohexene 4CH~2~), 2.51 (s, 3H, CH~3~), 3.60 (s, 2H, CH~2~), 4.78 (s, 2H, NH~2~), 6.97--8.32 (m, 4H, C~6~H~4~), 9.84 (s, 1H, NH); ^13^C-NMR: 19.4, 23.0, 25.1, 27.8 (cyclohexene 4CH~2~), 24.8 (CH~3~), 51.9 (triazine CH~2~), 115.8, 116.4 (2CN), 118.3, 118.9, 119.2, 121.6, 124.6, 133.2, 136.5, 136.9 139.6 (thiophene C, C~6~H~5~, C~6~H~4~), 156.0, 163.5 164.3 (3 C=N); *Anal.* Calcd. for C~21~H~20~N~8~S (416.50): C, 60.56; H, 4.84; N, 26.90; S, 7.70%. Found: C, 60.28; H, 5.03; N, 26.61; S, 7.88%.

*Ethyl 1-amino-6-(4-methylphenyl)-3-(α(2-hydrazo-4,5,6,7-tetra-hydrobenzo\[b\]thiophene-3-carboxyl-ate)acetonitrilo)-1,2,4-triazine*(**10c**). Brown crystals (from ethanol) Yield: 0.53 g (57%)**,** m.p. 90 °C; IR (KBr) υ/cm^−1^: 3400--3287 (NH~2~, NH), 2976, 2934, 2860 (2CH~3~, CH~2~), 2213 (CN), 1711 (C=O); ^1^H- NMR δ: 1.07--1.92 (m, 8H, cyclohexene 4CH~2~), 2.51 (s, 3H, CH~3~), 2.77 (t, 3H, J = 7.04 Hz, CH~3~), 3.36 (s, 2H, CH~2~), 4.24 (q, 2H, J = 7.04 Hz, CH~2~), 4.99 (s, 2H, NH~2~), 6.50--8.08 (m, 4H, C~6~H~4~), 9.88(s, 1H, NH); ^13^C-NMR: 14.5, 24.6 (2 CH~3~), 23.2, 23.6, 25.1, 27.6 (cyclohexene 4CH~2~), 55.4 (triazine CH~2~), 60.8 (ester CH~2~), 128.7, 129.0, 129.7, 132.1, 136.5, 138.9, 140.8 (C~6~H~5~, thiophene C), 115.9, 116.7 (2CN), 155.2, 158.0, 163.1 (3 C=N), 165.6 (CO); Anal. Calcd. for C~23~H~25~N~7~O~2~S (463.56): C, 59.59; H, 5.44; N, 21.15; S, 6.93%. Found: C, 59.83; H, 5.46; N, 20.91; S, 7.05%.

*1-Phenylamino-6-(4-methylphenyl)-3-(α-phenylhydrazoacetonitrilo)-1,2,4-triazine*(**10d**)*.* To a cold solution (0--5 °C) of compound **6b**(0.53 g, 1.64 × 10^−3^ mol) in ethanol (50 mL) containing sodium hydroxide (10 mL, 10%) was added with continuous stirring a solution of benzenediazonium chloride (1.64 × 10^−3^ mol) \[which was prepared by dissolving sodium nitrite (0.17 g, 2.47 × 10^−3^mol) in water, 2 mL was added to a cold solution of aniline (0.15 g, 1.64 × 10^−3^ mol) containing the appropriate amount of hydrochloric acid and with continuous stirring\]. The formed solid product was collected by filtration to give reddish brown crystals (from ethanol and few drops of dimethylformamide). Yield: 0.58 g (86%), m.p. 120 °C; IR (KBr) υ/cm^−1^: 3500--3422 (2NH), 3057 (CH aromatic), 3028, 2921(CH~3~, CH~2~), 2211 (CN), 1600 (C=C); ^1^H-NMR δ: 2.50 (s, 3H, CH~3~), 3.31 (s, 2H, CH~2~), 6.60--7.65 (m, 14H, 2C~6~H~5~, C~6~H~4~), 8.16, 9.05 (s, 2H, 2NH); ^13^C-NMR: 23.6 (CH~3~), 51.9 (triazine CH~2~), 115.6 (CN), 118.6, 118.7, 119.2, 120.1, 121.6, 124.8, 133.6, 134.8, 139.9 (2C~6~H~5~, C~6~H~4~), 156.6, 163.7, 164.0 (3 C=N); *Anal.* Calcd. for C~24~H~21~N~7~ (407.47): C, 70.74; H, 5.19; N, 24.06%. Found: C, 71.05; H, 5.38; N, 23.87%.

3.5. General Procedure for the Synthesis of ***10e*** and ***10f***
-------------------------------------------------------------------

To a cold solution (0--5 °C) of compound **6b**(0.40 g, 1.24 × 10^−3^ mol) in ethanol (50 mL) containing sodium hydroxide solution (10 mL, 10%) was added with continuous stirring a solution of either 3-cyano-4,5,6,7-terahydrobenzo\[b\]thiophene-2-diazonium chloride **(9b)** (1.24 × 10^−3^ mol) or ethyl 4,5,6,7-tetrahydrobenzo\[b\]thiophen-3-carboxylate-2-diazonium chloride **(9c)** (1.24 × 10^−3^ mol) \[which was prepared by dissolving sodium nitrite (0.12 g, 1.86 × 10^−3^ mol) in water, 2 mL was added to a cold solution of either the 2-amino-3-cyano-4,5,6,7-tetrahydrobenzo\[b\]thiophene (0.22 g, 1.99 × 10^−3^ mol) or ethyl 2-amino-4,5,6,7-tetrahydrobenzo\[b\]thiophene-3-carboxylate (0.28 g, 1.99 × 10^−3^ mol) dissolved in acetic acid (50 mL) containing the appropriate amount of hydrochloric acid and with continuous stirring\]. The solid product formed was collected by filtration and dried.

*1-Phenylamino-6-(4-methylphenyl)-3-(α-(3-cyano-2-hydrazo-4,5,6,7-tetrahydrobenzo\[b\]thiophene)-acetonitrilo)-1,2,4-triazine*(**10e**). Reddish brown crystals (from ethanol), yield: 0.34 g (55%), m.p. 190 °C; IR (KBr) υ/cm^−1^: 3500--3425 (2NH), 3030 (CH aromatic), 2930 (CH~3~), 2250, 2217 (2CN), 1606 (C=C); ^1^H-NMR δ: 1.63--2.34 (m, 8H, cyclohexene), 2.51 (s, 3H, CH~3~), 3.60 (s, 2H, CH~2~), 6.97--8.32 (m, 9H, C~6~H~5~, C~6~H~4~), 9.84, 10.00 (s, 2H, 2NH); ^13^C-NMR: 19.1, 23.3, 25.4, 27.4 (cyclohexene 4CH~2~), 24.9 (CH~3~), 51.7 (triazine CH~2~), 115.6, 116.3 (2CN), 118.3, 118.9, 119.2, 121.6, 124.6, 133.2, 136.5, 136.9 139.4 (thiophene C, C~6~H~5~, C~6~H~4~), 156.1, 163. 3, 164.6 (3 C=N). *Anal.* Calcd. for C~27~H~24~N~8~S (492.60): C, 65.83; H, 4.91; N, 22.75; S, 6.51%. Found: C, 65.96; H, 5.24; N, 22.55; S, 6.79%.

*Ethyl 1-phenylamino-6-(4-methylphenyl)-3-(α(2-hydrazo-4,5,6,7-tetrahydrobenzo-\[b\]thiophen-3-carboxylate)acetonitrilo)-1,2,4-triazine* (**10f**). Pale reddish brown crystals (from ethanol). Yield: 0.40 g (59%), m.p. 150--160 °C; IR (KBr) υ/cm^−1^: 3400--3287 (2NH), 2976, 2934, 2860 (2CH~3~, CH~2~), 2213 (CN), 1711 (C=O); ^1^H-NMR δ: 1.07--1.92 (m, 8H, cyclohexene), 2.51 (s, 3H, CH~3~), 2.77 (t, 3H, J = 6.89 Hz, CH~3~), 3.36 (s, 2H, CH~2~), 4.24 (q, 2H, J = 6.89 Hz, CH~2~), 6.50--8.08 (m, 9H, C~6~H~5~, C~6~H~4~), 9.88, 10.30 (2s, 2H, 2NH); ^13^C-NMR: 14.3, 24.8 (2 CH~3~), 23.0, 23.3, 25.1, 27.8 (cyclohexene 4CH~2~), 55.54 (triazine CH~2~), 60.8 (ester CH~2~), 128.7, 129.2, 129.7, 132.0, 136.5, 138.9, 140.8 (C~6~H~5~, thiophene C), 115.8, 116.5 (2CN), 155.2, 158.0, 163.3 (3 C=N), 165.6 (CO); Anal. Calcd. for C~29~H~29~N~7~O~2~S (539.65): C, 64.54; H, 5.42; N, 18.17; S, 5.94%. Found: C, 64.68; H, 5.23; N, 17.97; S, 6.20%.

3.6. General Procedure for the Synthesis of ***12a*** and ***12b***
-------------------------------------------------------------------

To a solution of compound **6a**(0.47 g, 1.91 × 10^−3^ mol) in ethanol (20 mL) containing triethylamine (0.5 mL), either malononitrile (0.12 g, 1.91 × 10^−3^ mol) or ethyl cyanoacetate (0.21 g, 1.91 × 10^−3^ mol) was added. The reaction mixture was heated under reflux for 3 hrs then poured onto a beaker containing an ice/water mixture and a few drops of hydrochloric acid. The solid product formed was collected by filtration and dried.

*3-Cyano-4,6-diamino-2-oxo-1-imino-(4-methyl-ω-hydrazinoaceto-phenonylidieno)pyridine*(**12a**). Brown crystals (from ethanol). Yield: 0.38 g (64%), m.p. 158 °C; IR (KBr) υ/cm^−1^: 3500--3227 (3NH~2~, NH), 3028 (CH aromatic), 2974 (CH~3~), 2919 (CH~2~), 2201 (CN), 1685 (C=O), 1600 (C=C); ^1^H-NMR δ: 2.51 (s, 3H, CH~3~), 3.38 (s, 2H, CH~2~), 4.38, 4.79, 5.30 (3s, 6H, 3NH~2~), 7.05--8.19 (m, 5H, pyridine H-3, C~6~H~4~), 10.82 (s, 1H, NH); ^13^C-NMR: 23.8 (CH~3~), 51.7 (CH~2~), 80.9, 89.5, 114.8, 125.6 (pyridine C), 117.9 (CN), 126.2, 128.0, 129.3, 129.6 (C~6~H~5~), 163.5 (C=O), 170.9 (C=N); *Anal.* Calcd. for C~15~H~17~N~7~O (311.34): C, 57.87; H, 5.50; N, 31.49%. Found: C, 57.96; H, 5.48; N, 31.68%.

*4-Amino-3-cyano-6-hydroxy-2-oxo-1-imino(4-methyl-ω-hydrazino-acetophenonylidieno)pyridine*(**12b**)*.*Pale brown crystals (from ethanol).Yield: 0.66 g (111%), m.p. 140 °C; IR (KBr) υ/cm^−1^: 3600--3227 (OH, 2NH~2~, NH), 3028 (CH aromatic), 2974 (CH~3~), 2919 (CH~2~), 2201 (CN), 1685 (C=O), 1600 (C=C); ^1^H-NMR δ: 2.50 (s, 3H, CH~3~), 3.39 (s, 2H, CH~2~), 4.34, 4.77, (2s, 4H, 2NH~2~), 7.05--8.19 (m, 5H, pyridine H-3, C~6~H~4~), 10.84 (s, 1H, NH), 12.64 (s, 1H, OH); ^13^C-NMR: 23.6 (CH~3~), 51.4 (CH~2~), 82.9, 89.5, 116.8, 125.9 (pyridine C), 117.9 (CN), 126.4, 128.0, 129.3, 129.6 (C~6~H~5~), 170.9, 176.5 (2C=N), 164.3 (2C=O); *Anal.* Calcd. for C~15~H~16~N~6~O~2~ (312.33): C, 57.68; H, 5.16; N, 26.90%. Found: C, 57.42; H, 5.09; N, 26.76%.

3.7. General Procedure for the Synthesis of ***12c*** and ***12d***
-------------------------------------------------------------------

To a solution of compound **6b**(0.60 g, 1.86 × 10^−3^ mol) in ethanol (20 mL) containing triethylamine (0.5 mL), either malononitrile (0.12 g, 1.86 × 10^−3^ mol) or ethyl cyanoacetate (0.21 g, 1.86 × 10^−3^ mol) was added. The reaction mixture was heated under reflux for 3 hrs then poured onto a beaker containing an ice/water mixture and a few drops of hydrochloric acid. The solid product formed was collected by filtration and dried.

*3-Cyano-4,6-diamino-2-oxo-1-imino-(4-methyl-ω-phenylhydrazino-acetophenonylidieno)pyridine*(**12c**) Green crystals (from ethanol). Yield: 0.51 g (70%), m.p. 80 °C; IR (KBr) υ/cm^−1^: 3480--3227 (2NH~2~, 2NH), 3028 (CH aromatic), 2974 (CH~3~), 2919 (CH~2~), 2201 (CN), 1685 (C=O), 1600 (C=C); ^1^H-NMR δ: 2.51 (s, 3H, CH~3~), 3.38 (s, 2H, CH~2~), 4.38, 4.79, (2s, 4H, 2NH~2~), 6.48--8.19 (m, 10H, pyridine H-3, C~6~H~5~, C~6~H~4~), 10.82, 11.20 (2s, 2H, 2NH); ^13^C-NMR: 23.7 (CH~3~), 51.9 (CH~2~), 80.7, 89.3, 114.9, 125.3 (pyridine C), 118.3 (CN), 126.4, 128.0, 129.3, 129.6 (C~6~H~5~), 170.9 (C=N), 162.5 (C=O); *Anal.* Calcd. for C~21~H~21~N~7~O (387.44): C, 65.10; H, 5.46; N, 25.30%. Found: C, 64.21; H, 5.36; N, 25.38%.

*4-Amino-3-cyano-6-hydroxy-2-oxo-1-imino(4-methyl-ω-phenyl-hydrazinoacetophenonylidieno) pyridine*(**12d**)*.* Yellowish green crystals (from ethanol). Yield: 0.58 g (80%)**.** Mp 84--100 °C; IR (KBr) υ/cm^−1^: 3600--3185 (OH, NH~2~, 2NH), 3027 (CH aromatic), 2975 (CH~3~), 2919 (CH~2~), 2206 (CN), 1684 (C=O), 1600 (C=C); ^1^H-NMR δ: 2.50 (s, 3H, CH~3~), 3.39 (s, 2H, CH~2~), 4.34 (s, 2H, NH~2~), 6.21 (s, 1H, pyridine H-3), 7.33--8.70 (m, 9H, C~6~H~5~, C~6~H~4~), 10.84, 11.22 (2s, 2H, 2NH), 12.64 (s, 1H, OH);^13^C-NMR: 23.6 (CH~3~), 51.6 (CH~2~), 80.2, 89.5, 114.5, 125.0 (pyridine C), 118.1 (CN), 126.2, 128.2, 129.5, 129.6 (C~6~H~5~), 164.8 (C=O), 170.9 (C=N); *Anal.* Calcd. for C~21~H~20~N~6~O~2~ (388.43): C, 64.93; H, 5.19; N, 21.63%. Found: C, 65.42; H, 5.69; N, 21.13%.

3.8. General Procedure for the Synthesis of ***14a*** and ***14b***
-------------------------------------------------------------------

To a solution of compound **6a**(0.52 g, 2.12 × 10^−3^ mol) in ethanol (20 mL) containing piperidine (0.5 mL), either acetylacetone (0.21 g, 2.21 × 10^−3^ mol) or ethyl acetoacetate (0.27 g, 2.21 × 10^−3^ mol) was added. The reaction mixture was heated under reflux for 3 hrs then poured onto a beaker containing an ice/water mixture and a few drops of hydrochloric acid. The solid product formed was collected by filtration and dried.

*3-Cyano-4,6-diamethyl-2-oxo-1-imino-(4-methyl-ω-hydrazinoaceto-phenonylidieno)pyridine*(**14a**) Brown crystals (from ethanol). Yield: 0.37 g (56%), m.p. 144 °C; IR (KBr) υ/cm^−1^: 3433--3229 (NH~2~, NH,), 3027 (CH aromatic), 2221 (CN), 1685 (C=O), 1600 (C=C); ^1^H-NMR δ: 2.34, 2.54, 3.04 (3s, 9H, 3CH~3~), 3.39 (s, 2H, CH~2~), 6.21 (s, 1H, pyridine H-3), 6.72--7.45 (m, 4H, C~6~H~4~), 10.84, 11.63 (s, 2H, 2NH); ^13^C-NMR: 16.0, 19.2, 24.3 (3CH~3~), 51.2 (CH~2~), 80.0, 88.3, 115.3, 123.9 (pyridine C), 116.8 (CN), 126.0, 127.9, 128.3, 129.1 (C~6~H~5~), 164.9 (C=O), 173.6 (C=N); Anal. Calcd. for C~17~H~19~N~5~O (309.37): C, 66.00; H, 6.19; N, 22.63%; found: C, 66.29; H, 6.23; N, 23.53%.

*3-Cyano-6-hydroxy-4-methyl-2-oxo-1-imino(4-methyl-ω-hydrazino-acetophenonylidieno)pyridine*(**14b**)*.* Brown crystals (from ethanol). Yield: 0.38 g (57%), m.p. 136 °C; IR (KBr) υ/cm^−1^: 3549--3321 (OH, NH~2~, NH), 3027 (CH aromatic), 2213 (CN), 1680 (C=O), 1600 (C=C); ^1^H-NMR δ: 2.53, 3.13 (3s, 9H, 3CH~3~), 3.39 (s, 2H, CH~2~), 6.22 (s, 1H, pyridine H-3), 6.73--7.39 (m, 4H, C~6~H~4~), 10.85, 11.33 (s, 2H, 2NH), 12.21 (s, 1H, OH); ^13^C-NMR: 16.1, 19.0, 24.3 (3CH~3~), 51.3 (CH~2~), 80.2, 88.3, 115.3, 152.1 (pyridine C), 116.6 (CN), 126.3, 127.6, 128.3, 129.1 (C~6~H~5~), 165.3 (C=O), 173.8 (C=N); *Anal*. Calcd. for C~16~H~17~N~5~O~2~ (311.34): C, 61.44; H, 5.50; N, 22.49%; found: C, 61.23; H, 5.67; N, 22.30%.

3.9. General Procedure for the Synthesis of ***14c*** and ***14d***
-------------------------------------------------------------------

To a solution of compound **6b**(0.60 g, 1.86 × 10^−3^ mol) in ethanol (20 mL) containing piperidine (0.5 mL), either acetylacetone (0.18 g, 1.86 × 10^−3^ mol) or ethyl acetoacetate (0.24 g, 1.86 × 10^−3^ mol) was added. The reaction mixture was heated under reflux for 3 hrs then poured onto a beaker containing an ice/water mixture and a few drops of hydrochloric acid. The solid product formed was collected by filtration and dried.

*3-Cyano-4,6-diamethyl-2-oxo-1-imino-(4-methyl-ω-phenylhydrazino-acetophenonylidieno)pyridine*(**14c**) Yellowish brown crystals (from ethanol). Yield: 0.61 g (85%), m.p. 100 °C; IR (KBr) υ/cm^−1^: 3450--3229 (2NH), 3027 (CH aromatic), 2213 (CN), 1680 (C=O), 1600 (C=C); ^1^H-NMR δ: 2.34, 2.51, 3.01 (3s, 9H, 3CH~3~), 3.37 (s, 2H, CH~2~), 6.21 (s, 1H, pyridine H-3), 6.50--8.41 (m, 9H, C~6~H~5~, C~6~H~4~), 10.82, 12.63 (s, 2H, 2NH); ^13^C-NMR: 16.3, 19.1, 24.3 (3CH~3~), 51.5 (CH~2~), 80.3, 88.6, 115.0, 127.7, 155.8 (pyridine C), 116.5 (CN), 118.7, 119.0, 120.8, 122.5, 126.0, 127.8, 128.7, 129.8 (C~6~H~5~, C~6~H~4~), , 166.2 (C=O), 173.6 (C=N); *Anal*. Calcd. for C~23~H~23~N~5~O (385.47): C, 71.66; H, 6.01; N, 18.16%; found: C, 71.86; H, 5.98; N, 17.99%.

*3-Cyano-6-hydroxy-4-methyl-2-oxo-1-imino(4-methyl-ω-phenyl-hydrazinoacetophenonylidieno)-pyridine*(**14d**)*.*Yellowish brown crystals (from ethanol). Yield: 0.48 g (66%). m.p. 96 °C; IR (KBr) υ/cm^−1^: 3600--3220 (OH, 2NH), 3027 (CH aromatic), 2211 (CN), 1682 (C=O), 1600 (C=C); ^1^H-NMR δ: 2.51, 3.00 (2s, 6H, 2CH~3~), 3.40 (s, 2H, CH~2~), 6.54 (s, 1H, pyridine H-3), 7.34--8.40 (m, 9H, C~6~H~5~, C~6~H~4~), 9.62, 10.82 (2s, 2H, 2NH), 12.65 (s, 1H, OH); ^13^C-NMR: 16.3, 19.4, 24.6 (3CH~3~), 51.5 (CH~2~), 80.8, 88.4, 116.5, 155.4 (pyridine C), 116.5 (CN), 118.8, 119.0, 120.3, 121.7, 126.0, 127.8, 128.9, 129.0 (C~6~H~5~, C~6~H~4~), , 166.4 (C=O), 173.9 (C=N); *Anal*. Calcd. for C~22~H~21~N~5~O~2~ (387.44): C, 68.20; H, 5.46; N, 18.07%; Found: C, 68.49; H, 5.84; N, 17.79%.

*2-Acetonitrilo-5-(4-methylphenyl)-1,3,4-oxadiazine* (**15**)*.* A solution of compound **3** (1.00 g, 3.39 × 10^−3^ mol) in sodium ethoxide (50 mL) was heated under reflux for 3 hrs then poured onto a beaker containing an ice/water mixture and a few drops of hydrochloric acid. The formed solid product was collected by filtration and dried to give pale brown crystals (from ethanol). Yield 0.39 g (54%), m.p. 190--193 °C; IR (KBr) υ/cm^−1^: 3028 (CH aromatic), 2998 (CH~3~), 2922, 2854 (2CH~2~), 2210 (CN), 1673 (C=N), 1609 (C=C); ^1^H-NMR δ: 2.51 (s, 3H, CH~3~), 3.35, 4.42 (2s, 4H, 2CH~2~), 7.00--8.40 (m, 4H, C~6~H~4~); ^13^C-NMR: 24.4 (CH~3~), 20.3 (CH~2~), 64.3 (oxadiazine CH~2~), 116.9 (CN), 126.0, 127.8, 128.9, 129.0, 133.1 (C~6~H~5~), 170.5 (C=N); *Anal*. Calcd. for C~12~H~11~N~3~O (213.24): C, 67.59; H, 5.19; N, 19.70%; found: C, 67.70; H, 5.38; N, 19.88%.

*2-(α-Benzalacetonitrilo)-5-(4-methylphenyl)-1,3,4-oxadiazine hydrochloride*(**16**)*.* To a solution of compound **3** (2.00 g, 6.79 × 10^−3^ mol) in ethanol (30 mL) containing piperidine (0.5 mL), benzaldehyde (0.72 g, 6.79 × 10^−3^ mol) was added. The reaction mixture was heated under reflux for 3 hrs then poured onto a beaker containing an ice/water mixture with a few drops of hydrochloric acid. The formed solid product was collected by filtration and dried to afford brown crystals (from ethanol). Yield: 1.35 g (58%), m.p. 100 °C; IR (KBr) υ/cm^−1^: 3050 (CH aromatic), 3029 (CH~3~), 2921 (CH~2~), 2830 (CH), 2216 (CN), 1604 (C=C); ^1^H-NMR δ: 2.51 (s, 3H, CH~3~), 4.22 (s, 2H, CH~2~), 5.16 (s, 1H, =CH), 7.35--8.02 (m, 9H, C~6~H~5~, C~6~H~4~); ^13^C-NMR: 24.6 (CH~3~), 63.8 (oxadiazine CH~2~), 116.7 (CN), 118.2 (CH=C), 120.4, 121.9, 124.5, 126.2, 127.4, 127.9, 129.2, 133.9 (C~6~H~4~, C~6~H~5~), 144.2 (CH=C), 171.5, 173.9 (2C=N); *Anal*. Calcd. for C~19~H~15~N~3~O (301.34): C, 75.73; H, 5.02; N, 13.94%; found: C, 75.52; H, 4.91; N, 14.31%.

*2-(α-Phenylhydrazoacetonitrilo)-5-(4-methylphenyl)1,3,4-oxadiazine*(**17**)*.* To a cold solution (0--5 °C) of compound **15**(1.00 g, 3.39 × 10^−3^ mol), in ethanol (50 mL) was added with continuous stirring benzenediazonium chloride (3.39 × 10^−3^ mol) \[which was prepared by dissolving sodium nitrite (0.35 g, 5.09 × 10^−3^ mol) in water, 2 mL was added to a cold solution of aniline (0.31 g, 3.39 × 10^−3^ mol) containing the appropriate amount of hydrochloric acid and with continuous stirring\]. The solid product formed after adjusting the pH 6 and stirring was collected by filtration and dried to give reddish brown crystals (from ethanol and dimethylformamide). Yield: 0.96 g (89%), m.p. 130 °C; IR (KBr) υ/cm^−1^: 3300--3215 (NH), 3057 (CH aromatic), 3030 (CH~3~), 2920 (CH~2~), 2219 (CN), 1679 (C=N), 1603 (C=C); ^1^H-NMR δ: 2.52 (s, 3H, CH~3~), 3.38 (s, 2H, CH~2~), 7.21--8.82 (m, 9H, C~6~H~5~, C~6~H~4~), 10.22 (s, 1H, NH). ). ^13^C-NMR: 24.3 (CH~3~), 63.0 (oxadiazine CH~2~), 116.5 (CN), 121.5, 121.9, 124.0, 123.5, 126.7, 127.0, 127.6, 129.2, 133.0 (C~6~H~4~, C~6~H~5~), 166.9, 170.5, 173.9 (3C=N). *Anal*. Calcd. for C~18~H~15~N~5~O (317.35): C, 68.12; H, 4.76; N, 22.06%; found: C, 67.92; H, 4.91; N, 21.25%.

4. Conclusions
==============

In this work cyanoacetyl hydrazine (*1*) reacted with α-haloketone **2** to afford the α-bromohydrazide-hydrazone derivative **3**. The latter compound was used in a series of heterocyclic transformations to give compounds that were tested as antitumor agents. The 2-hydroxypyridine derivatives **14b** showed the highest inhibitory activity.
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